Statin Medication Improves Five-Year Survival Rates in Patients with Head and Neck Cancer: A Retrospective Case-Control Study of about 100,000 Patients.

Jonas Wüster Max HeilandSusanne NahlesFilippo De Braud Saskia Preissner

Published in: Cancers (2023)

The results indicate that the five-year survival of head and neck cancer patients is significantly improved by statin medication. As this study was conducted retrospectively, our data must be interpreted with caution, especially since other potential influencing factors and the initial tumor stage were not available.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
cardiovascular disease
prognostic factors
coronary artery disease
emergency department
type diabetes
machine learning
risk assessment
patient reported outcomes
patient reported